Markets
Is Atossa Therapeutics Inc. (NASDAQ:ATOS) Still Worth A Bite?
Atossa Therapeutics Inc. (NASDAQ:ATOS) has a beta of 2.19. The stock’s Relative Strength Index (RSI) is 59.94, with weekly volatility at 24.74% and ATR at
Atossa Therapeutics Inc. (NASDAQ:ATOS) has a beta of 2.19. The stock’s Relative Strength Index (RSI) is 59.94, with weekly volatility at 24.74% and ATR at
Atossa Therapeutics Inc. (NASDAQ:ATOS) shares traded higher over the last trading session, gaining 30.09% on 06/07/21. The shares fell to a low of $4.90 before
Atossa Therapeutics Inc. (NASDAQ:ATOS) shares traded higher over the last trading session, gaining 20.19% on 06/01/21. The shares fell to a low of $3.31 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne